Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphomaTatsuro Jo, Ritsuko Kubota‐Koketsu, Kaori Matsuzaka et al.|Anticancer Research|2020Cited by 13
Live attenuated VZV vaccination induces antitumor immunity in ATLL patientsTatsuro Jo, Kazuto Shigematsu, Takahiro Sakai et al.|Cancer Immunology Immunotherapy|2022Cited by 8
<scp>HTLV</scp>‐1 Tax‐specific memory cytotoxic T lymphocytes in long‐term survivors of aggressive‐type adult T‐cell leukemia/lymphomaTatsuro Jo, Kazuto Shigematsu, Kazuhiro Noguchi et al.|Cancer Medicine|2022Cited by 8
Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with RomidepsinTatsuro Jo, Kazuto Shigematsu, Takahiro Sakai et al.|Case Reports in Oncology|2020Cited by 4
Induction of Effector and Memory Cellular Immunity in a Patient with Long-Term Complete Molecular Response to Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaTatsuro Jo, Jun Taguchi, Haruna Shioya et al.|Case Reports in Oncology|2020Cited by 2